|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2001-11-12
|
|
pubmed:abstractText |
Nasal congestion is the predominant symptom in perennial allergic rhinitis (PAR), and it seems to be mainly related to the late-phase inflammatory events. The present pilot study aimed to evaluate the therapeutic effect exerted by fexofenadine in patients with PAR due to mite allergy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0105-4538
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1068-70
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11703220-Adolescent,
pubmed-meshheading:11703220-Adult,
pubmed-meshheading:11703220-Animals,
pubmed-meshheading:11703220-Dose-Response Relationship, Drug,
pubmed-meshheading:11703220-Double-Blind Method,
pubmed-meshheading:11703220-Female,
pubmed-meshheading:11703220-Histamine H1 Antagonists,
pubmed-meshheading:11703220-Humans,
pubmed-meshheading:11703220-Male,
pubmed-meshheading:11703220-Middle Aged,
pubmed-meshheading:11703220-Mites,
pubmed-meshheading:11703220-Nasal Mucosa,
pubmed-meshheading:11703220-Pilot Projects,
pubmed-meshheading:11703220-Rhinitis, Allergic, Perennial,
pubmed-meshheading:11703220-Sneezing,
pubmed-meshheading:11703220-Terfenadine,
pubmed-meshheading:11703220-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Fexofenadine reduces nasal congestion in perennial allergic rhinitis.
|
|
pubmed:affiliation |
Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
